{"id":"https://genegraph.clinicalgenome.org/r/8916463d-6d3c-489e-90cb-53e77a29c593v1.0","type":"EvidenceStrengthAssertion","dc:description":"BUBR1 protein encoded by BUB1B gene is an important protein in the spindle assembly checkpoint. Constitutional homozygotes of hypomorphic mutations or compound heterozygote of a null mutation and a missense/hypomorphic mutation in the BUB1B gene cause the rare human disorder mosaic variegated aneuploidy (MVA) syndrome type I (MIM 257300). Hanks S et al., (2004) identified 6 individuals from 5 unrelated families with typical phenotypes of MVA carry biallelic BUB1B mutations. Rio Frio T et al. (2010) identified a male of 34 yr-old from a consanguineous family with MVA phenotype and many types of cancers homozygous for BUB1B 2386-11A>G mutation. Ochiai H et al., (2004) found a Japanese infant with MVA homozygous for mutation ss802470619,NC_000015.10:g.40117088G>A (GRCh38), which is the second allele to the seven individuals who had one allele previously identified (Matsuura S, et al. (2006)). This mutation is a hypomorphic mutation that down regulate the expression of BUB1B gene.  Using human HeLa cells Bohers et al. (2008) showed  the levels of PCS (premature chromatid separation) and aneuploidy were correlated to the decrease of BUB1B expression. BubR1−/− embryos present mosaicism with a significant percentage of aneuploid cells and premature chromatic separation, growth retardation and marked developmental abnormalities. Progressive apoptosis and reduced cell proliferation finally lead to severe morphological malformation and embryonic death (Schmid M et al., 2014.). More evidence is available in literatures, but the maximum score from genetic evidence and experimental evidences has been reached. In summary, BUB1B gene is definitively associated with mosaic variegated aneuploidy syndrome 1. Variants in this gene have been independently and replicably identified in many individuals with MVA.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/8916463d-6d3c-489e-90cb-53e77a29c593","GCISnapshot":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2021-02-22T23:35:15.828Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2019-11-22T14:53:26.352Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fdafd7d-4124-45b7-8f09-546aac408ad6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default score. This is an individual of MVA reported in Kajii T et al., 2001. One allele, IVS10-5A>G identified in Matsuura S et al., 2006; the second allele identified in Ochiai H et al., 2014. The second allele is reported in a different article listed at 24344301. It is ss802470619 (G/A), located 44kb upstream of a BUB1B transcription start site, cosegregated with the disease. This intergenic mutation is involved in the down-regulation of BUB1B expression. A more than 50% reduction of BUBR1 function is involved in the MVA syndrome and the biallelic hypomorphic mutations are causative of PCS (MVA) syndrome.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fbbcb77d-2609-4197-a543-1b692e478a31","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16411201","rdfs:label":"patient 2","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":3,"detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"premature chromatid separation of all chromosomes, mosaicism for various trisomies adn monosomies","phenotypes":["obo:HP_0002667","obo:HP_0000252","obo:HP_0001305","obo:HP_0001511"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3fdafd7d-4124-45b7-8f09-546aac408ad6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16411201","allele":[{"id":"https://genegraph.clinicalgenome.org/r/2478425f-1014-4681-ba39-a9359bafb681","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.1402-5A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6769"}},{"id":"https://genegraph.clinicalgenome.org/r/559b4441-5b3f-4b2c-9a7f-6adddd828f08","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000015.10:g.40117088G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA268757149"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b073c2f-a3d4-4256-aa28-2c24832adfa2_proband_segregation","type":"FamilyCosegregation","dc:description":"two affected including one miscarried 2 days after prenatal cytogenetic diagnosis of MVA and no family pedigree available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","rdfs:label":"Family 4","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/9b073c2f-a3d4-4256-aa28-2c24832adfa2","type":"Family","rdfs:label":"Family 4","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7807a7ab-64b9-4e30-bd6f-86129e8f3e9c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","rdfs:label":"family 4 girl","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"gene sequencing on both parents","firstTestingMethod":"Denaturing gradient gel","phenotypeFreeText":"Thumb adduction, hemangioma, constitutional mosaicism for chromosomal gains and losses","phenotypes":["obo:HP_0002859","obo:HP_0003616","obo:HP_0000786","obo:HP_0000252"],"previousTesting":true,"previousTestingDescription":"postnatal chromosome studies","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6e0822ad-f38f-46dc-a3ce-1c8961118bf9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","allele":[{"id":"https://genegraph.clinicalgenome.org/r/59908091-a8f8-41dd-a9e1-52297e615b10","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.1402-1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6767"}},{"id":"https://genegraph.clinicalgenome.org/r/48cb879e-a834-429a-8ea8-2ac8417101ea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.1649G>A (p.Arg550Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6766"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Thumb adduction, hemangioma, constitutional mosaicism for chromosomal gains and losses","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000252","obo:HP_0002859","obo:HP_0003616","obo:HP_0000786"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7807a7ab-64b9-4e30-bd6f-86129e8f3e9c"}},{"id":"https://genegraph.clinicalgenome.org/r/0cc0bed5-9cee-4217-9c30-bce638d6fb7a_proband_segregation","type":"FamilyCosegregation","dc:description":"Small pedigree with nuclear family members and one affected member only.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24344301","rdfs:label":"Japanese family","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/0cc0bed5-9cee-4217-9c30-bce638d6fb7a","type":"Family","rdfs:label":"Japanese family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/73f1af44-8034-418a-91b5-348435c48340","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24344301","rdfs:label":"KH01","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":2,"detectionMethod":"deep sequencing and common ancestral haplotype analysis of  intergenic region upstream of BUB1B","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"PCS and mosaic aneuploidy","phenotypes":"obo:HP_0002859","previousTesting":true,"previousTestingDescription":"sequencing BUB1B","secondTestingMethod":"Genotyping","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3e914b8f-ebac-415e-9f97-f9bd2ac7f99f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24344301","allele":{"id":"https://genegraph.clinicalgenome.org/r/559b4441-5b3f-4b2c-9a7f-6adddd828f08"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"PCS and mosaic aneuploidy","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0002859","proband":{"id":"https://genegraph.clinicalgenome.org/r/73f1af44-8034-418a-91b5-348435c48340"}},{"id":"https://genegraph.clinicalgenome.org/r/2d1c1add-d63c-4eb0-8aaf-671bafd44052_proband_segregation","type":"FamilyCosegregation","dc:description":"trio small nuclear family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16411201","rdfs:label":"Family 2","family":{"id":"https://genegraph.clinicalgenome.org/r/2d1c1add-d63c-4eb0-8aaf-671bafd44052","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fbbcb77d-2609-4197-a543-1b692e478a31"}},"phenotypeFreeText":"premature chromatid separation of all chromosomes, mosaicism for various trisomies adn monosomies","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001305","obo:HP_0001511","obo:HP_0002667","obo:HP_0000252"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/fbbcb77d-2609-4197-a543-1b692e478a31"}},{"id":"https://genegraph.clinicalgenome.org/r/a557acdf-73e7-4bd4-8b96-55a68d53bfb9_proband_segregation","type":"FamilyCosegregation","dc:description":"small nuclear family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16411201","rdfs:label":"Family 1","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/a557acdf-73e7-4bd4-8b96-55a68d53bfb9","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ac48737d-1013-4c01-80e2-de099322735d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16411201","rdfs:label":"patient 1","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":3,"detectionMethod":"PCR, microsatellite markers","firstTestingMethod":"PCR","phenotypeFreeText":"premature chromatid separation of all chromosomes, mosaicism for various trisomies adn monosomies","phenotypes":["obo:HP_0001305","obo:HP_0100020","obo:HP_0002667","obo:HP_0007957","obo:HP_0000252","obo:HP_0001511"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b394ce19-fa21-43e8-a399-7a85aa75bbd4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16411201","allele":[{"id":"https://genegraph.clinicalgenome.org/r/559b4441-5b3f-4b2c-9a7f-6adddd828f08"},{"id":"https://genegraph.clinicalgenome.org/r/df8718be-adec-427c-ba6e-cec15347db1f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.1833del (p.Phe611fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6768"}}]}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"premature chromatid separation of all chromosomes, mosaicism for various trisomies adn monosomies","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002667","obo:HP_0100020","obo:HP_0001511","obo:HP_0007957","obo:HP_0000252","obo:HP_0001305"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ac48737d-1013-4c01-80e2-de099322735d"}},{"id":"https://genegraph.clinicalgenome.org/r/d7df4a12-73ec-4ead-87a5-7a2856a91aba_proband_segregation","type":"FamilyCosegregation","dc:description":"one affected only and no family pedigree available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","rdfs:label":"Family 2","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/d7df4a12-73ec-4ead-87a5-7a2856a91aba","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0a4d2c53-1f83-432f-8d73-97509353ad8a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","rdfs:label":"family 2 proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":2,"detectionMethod":"conformation sensitive gel electrophoresis","firstTestingMethod":"Denaturing gradient gel","phenotypeFreeText":"eye anomalies, constitutional mosaicism for chromosomal gains and losses","phenotypes":["obo:HP_0001511","obo:HP_0000252","obo:HP_0000003"],"previousTesting":true,"previousTestingDescription":"Chromosome studies","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f66d622f-d259-4e73-bf92-68b51c76409e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","allele":[{"id":"https://genegraph.clinicalgenome.org/r/181325fc-49d5-49a6-bdba-1bf3fa3607f8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.2441G>A (p.Arg814His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6764"}},{"id":"https://genegraph.clinicalgenome.org/r/a9d2b90d-3e02-425a-8189-9267fa834d02","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.2208_2211dup (p.Ser738Valfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6763"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"eye anomalies, constitutional mosaicism for chromosomal gains and losses","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000252","obo:HP_0000003","obo:HP_0001511"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0a4d2c53-1f83-432f-8d73-97509353ad8a"}},{"id":"https://genegraph.clinicalgenome.org/r/be994231-f14c-4658-89bd-74883a12dab7_proband_segregation","type":"FamilyCosegregation","dc:description":"only the proband carries homozygous mutations tested.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21190457","rdfs:label":"Family 1","estimatedLodScore":0.75,"family":{"id":"https://genegraph.clinicalgenome.org/r/be994231-f14c-4658-89bd-74883a12dab7","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/87c0760e-7c6d-4639-869b-8d618c1c44d9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21190457","rdfs:label":"proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":68,"detectionMethod":"","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"premature chromatid separation, mosaic variegated aneuploidy","phenotypes":["obo:HP_0002672","obo:HP_0012126","obo:HP_0003003"],"previousTesting":true,"previousTestingDescription":"Analysis of DNA, RNA, or protein for APC, the mutY, MUTYH, MLH1, MLH2, MSH6 and PMS2.\nChromosome and microarray studies","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/abc32e29-5ce4-4922-8be4-536e99c9c66a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21190457","allele":{"id":"https://genegraph.clinicalgenome.org/r/cbb3a190-5e7d-4748-a993-dc0d5a7612a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.2386-11A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/30279"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"phenotypeFreeText":"premature chromatid separation, mosaic variegated aneuploidy, abnormal chromosome analysis with premature chromatid separation","phenotypeNegativeAlleleNegative":6,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0012126","obo:HP_0002672","obo:HP_0003003"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/87c0760e-7c6d-4639-869b-8d618c1c44d9"}},{"id":"https://genegraph.clinicalgenome.org/r/1e0cc087-080d-49be-8955-ee50ae547d5f_proband_segregation","type":"FamilyCosegregation","dc:description":"one affected only and on obvious family pedigree available.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","rdfs:label":"Family 3","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/1e0cc087-080d-49be-8955-ee50ae547d5f","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/73cb60d6-931d-4245-961d-433841cf1fce","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","rdfs:label":"Family 3 proband","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":4,"detectionMethod":"sequencing on both parents","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Denaturing gradient gel","phenotypeFreeText":"eye anomalies, hypothyroidism, anemia, constitutional mosaicism for chromosomal gains and losses","phenotypes":["obo:HP_0000252","obo:HP_0001631","obo:HP_0001511","obo:HP_0001642"],"previousTesting":true,"previousTestingDescription":"Chromosome studies","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3ff458c4-32d9-4540-a31c-29f5a9f845eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a9d2b90d-3e02-425a-8189-9267fa834d02"},{"id":"https://genegraph.clinicalgenome.org/r/746bf347-a8f2-4287-ba88-3d15d15f5185","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.3035T>C (p.Leu1012Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6765"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"eye anomalies, hypothyroidism, anemia, constitutional mosaicism for chromosomal gains and losses","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000252","obo:HP_0001631","obo:HP_0001642","obo:HP_0001511"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/73cb60d6-931d-4245-961d-433841cf1fce"}},{"id":"https://genegraph.clinicalgenome.org/r/32558c3f-5210-40d9-bfa0-b23e108f63b7_proband_segregation","type":"FamilyCosegregation","dc:description":"one affected individual only, and no family pedigree available.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","rdfs:label":"Family 1","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/32558c3f-5210-40d9-bfa0-b23e108f63b7","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/a497a971-aa35-4e85-8d07-161d1227b7ce","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","rdfs:label":"family 1 boy","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":7,"detectionMethod":"conformation sensitive gel electrophoresis and entire gene sequencing on both parents","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Denaturing gradient gel","phenotypeFreeText":"Crytorchidism, constitutional mosaicism for chromosomal gains\nand losses","phenotypes":["obo:HP_0001562","obo:HP_0000252","obo:HP_0001511","obo:HP_0008897","obo:HP_0003616","obo:HP_0006743"],"previousTesting":true,"previousTestingDescription":"Prenatal and postnatal chromosome studies","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2ad210d6-47a9-479f-a2a0-ea89326a83ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15475955","allele":[{"id":"https://genegraph.clinicalgenome.org/r/c6d9ebd4-2e52-4e80-840d-34910ca34762","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.2530C>T (p.Leu844Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6761"}},{"id":"https://genegraph.clinicalgenome.org/r/7a7a8893-dba3-40fa-8aed-1eb2f73cde26","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001211.5(BUB1B):c.580C>T (p.Arg194Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6760"}}],"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Crytorchidism, constitutional mosaicism for chromosomal gains\nand losses","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001562","obo:HP_0006743","obo:HP_0003616","obo:HP_0008897","obo:HP_0000252","obo:HP_0001511"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a497a971-aa35-4e85-8d07-161d1227b7ce"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/abc32e29-5ce4-4922-8be4-536e99c9c66a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default score. This individual is homozygous for NM_001211.5(BUB1B):c.2386-11A>G. This mutations creates a de novo splice site that is favored over the authentic site. Nonsense-mediated mRNA decay was confirmed with mutant mRNA from persons with this mutation. No mutant protein was produced. Small amount of normal BUBR1 protein from fibroblasts of this patient was present in the kinetochores. BUBR1 interact with APC, which may underlie the susceptibility to GI neoplasia. Cytogenetic studies showed mosaic aneuploidies, predominantly trisomies.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87c0760e-7c6d-4639-869b-8d618c1c44d9"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b394ce19-fa21-43e8-a399-7a85aa75bbd4_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default score. This is a family with the proband of MVA reported in Kawame et al., 1999; one allele, 1833delT identified in Matsuura S et al., 2006; the second allele identified in Ochiai H et al., 2014. The second allele is reported in a different article listed at 24344301. It is ss802470619 (G/A), located 44kb upstream of a BUB1B transcription start site, cosegregated with the disease. This intergenic mutation is involved in the down-regulation of BUB1B expression. A more than 50% reduction of BUBR1 function is involved in the MVA syndrome and the biallelic hypomorphic mutations are causative of PCS (MVA) syndrome.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac48737d-1013-4c01-80e2-de099322735d"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6e0822ad-f38f-46dc-a3ce-1c8961118bf9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default score. RT-PCR analyses showed that  the above splicing mutation causes deletion of exon 11, resulting in a truncated protein of 482 amino acids. Bub1b-/-  mouse model die in utero, Bub1b+/- have defective spindle checkpoint activation and develop lung and colon cancers in response to carcinogen. Bub1b H/H mice, develop aneuploidy, cataracts and growth retardation, which are characteristic of MVA, but do not have an increased cancer incidence, these mice also showed features of premature aging, but not have typical features of human premature aging syndromes. This is the female proband in family 4 (4a) who developed an embryonal rhabdomyosarcoma of the vagina at 5 months of age: both mutations present as in the constitutional DNA; the second affected male 9(4b) pregnancy  with the same mutation spontaneously miscarried at 2 days after prenatal cytogenetic diagnosis of MVA, chinese origin, no consanguinity","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7807a7ab-64b9-4e30-bd6f-86129e8f3e9c"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f66d622f-d259-4e73-bf92-68b51c76409e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default score. Bub1b-/-  mouse model die in utero, Bub1b+/- have defective spindle checkpoint activation and develop lung and colon cancers in response to carcinogen. Bub1b H/H mice, develop aneuploidy, cataracts and growth retardation, which are characteristic of MVA, but do not have an increased cancer incidence, these mice also showed features of premature aging, but not have typical features of human premature aging syndromes. This individual had a missense mutation, c.2441G>A(p.Arg814His) and a mutation, c.2208_2211dup (p.Ser738Valfs) that resulted in premature protein truncation. None of the mutations have been reported in more than 200 BUB1B mutation analyses in colorectal cancers, lung cancers and glioblastomas, and none were present in 384 normal control chromosomes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a4d2c53-1f83-432f-8d73-97509353ad8a"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3ff458c4-32d9-4540-a31c-29f5a9f845eb_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default score. Bub1b-/-  mouse model die in utero, Bub1b+/- have defective spindle checkpoint activation and develop lung and colon cancers in response to carcinogen. Bub1b H/H mice, develop aneuploidy, cataracts and growth retardation, which are characteristic of MVA, but do not have an increased cancer incidence, these mice also showed features of premature aging, but not have typical features of human premature aging syndromes. This individual had a missense mutation, c.3035T>C (p.Leu1012Pro) and a mutation, c.2208_2211dup (p.Ser738Valfs) that resulted in premature protein truncation. None of the mutations have been reported in more than 200 BUB1B mutation analyses in colorectal cancers, lung cancers and glioblastomas, and none were present in 384 normal control chromosomes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73cb60d6-931d-4245-961d-433841cf1fce"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2ad210d6-47a9-479f-a2a0-ea89326a83ab_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default score. Bub1b-/-  mouse model die in utero, Bub1b+/- have defective spindle checkpoint activation and develop lung and colon cancers in response to carcinogen. Bub1b H/H mice, develop aneuploidy, cataracts and growth retardation, which are characteristic of MVA, but do not have an increased cancer incidence, these mice also showed features of premature aging, but not have typical features of human premature aging syndromes.  The p.Leu844Phe is maternal allele, another allele Q921H (ClinVar ID 6762) was also identified as maternal allele. ClinVar reports this is VOUS.  None of the mutations have been reported in more than 200 BUB1B mutation analyses in colorectal cancers, lung cancers and glioblastomas, and none were present in 384 normal control chromosomes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a497a971-aa35-4e85-8d07-161d1227b7ce"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3e914b8f-ebac-415e-9f97-f9bd2ac7f99f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Default score. This individual is homozygous for this mutation the ss802470619 (G/A) (CA268757149). This mutation is located 44 kb upstream of a BUB1B transcription start site, an intergenic region, cosegregated with the disease. Both parents are heterozygous. This intergenic mutation is involved in the down-regulation of BUB1B expression, the expression level from this individual showed much higher than those of a patient with a truncating plus this intergenic mutation but lower than those of a carrier with a truncating mutation of BUB1B. This infant had PCS in 67% of lymphocytes, which was lower than in the patient with a truncating plus intergenic mutation and higher than in the parents with heterozygous mutations. A more than 50% reduction of BUBR1 function is involved in the MVA syndrome and the biallelic hypomorphic mutations are causative of PCS (MVA) syndrome. The cultured human cell clones showed increased PCS frequency and MVA, which are the hallmarks of the syndrome. This variant was also found in other seven Japanese families as the second allele to one of the null alleles identified in 2006 by Matsuura S. et al. in 2006 and the proband in a family with MVA as the second allele to a null allele of no transcript generated by Hanks S et al. in 2004.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73f1af44-8034-418a-91b5-348435c48340"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b700a6b-7757-40ea-a604-ad0fadeb3008","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ccad221d-2569-44e1-beff-8ea22442e307","type":"Finding","dc:description":"BubR1−/− embryos present mosaicism with a significant percentage of aneuploid cells and premature chromatic separation, growth retardation and marked developmental abnormalities. Progressive apoptosis and reduced cell proliferation finally lead to severe morphological malformation and embryonic death.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24981203","rdfs:label":"western blot and karyotyping","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8f0b2d38-818f-4e63-abb9-e2e7e67ca70d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5fbdca35-30c0-47d6-a3fc-3082529a2109","type":"Finding","dc:description":"Quantitative RT-PCR analysis showed reduction of BUB1B transcripts in the cell clones with biallelically introduced substitutions.  Metaphase chromosome analysis showed alteration of  chromosome numbers and  high rate of premature chromatid separation (PCS), insensitive to the spindle assembly checkpoint in those  biallelic substitutions at ss804270619.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24344301","rdfs:label":"TALEN-mediated twostep single-base-pair editing strategy","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4542c287-1945-429e-8d33-6723e26dba29","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d532bec-9ba0-433e-b83d-f78b3d179b8c","type":"Finding","dc:description":"BUB1B short hairpin RNAs (shRNAs) induced reduction of BUB1B expression in human model cells.  The levels of PCS (premature chromatid separation) and aneuploidy in transduced cells were correlated to the decrease of BUB1B expression below 50%. Both PCS and aneupoidy are phenotypes in human MVA.  This provides a biological explanation for the mode of inheritance of PCS, which is dominant, and of MVA, which can be recessive in some families and result from the combination of a null allele associated to a common hypomorphic allele in others.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18932004","rdfs:label":"western analysis and mitotic index assay","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b9baa6b-94ac-4e88-a291-bffd2e00ea0b","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9eedbb0-f12f-4236-bc9e-6cc15c7d8678","type":"FunctionalAlteration","dc:description":"The infant (KH01) is homozygous for NC_000015.10:g.40117088G>A (GRCh38, a G>A mutation located 44kb upstream of a BUB1B transcription start site. Western blot analysis showed reduced BUBR1 expression in PB of infant (KH01), increased PCS frequency (67% of lymphocytes) and mosaic aneuploidy (17%).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24344301","rdfs:label":"Western blot analysis"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7a8c9f31-428d-4da6-95ff-91d649b747a2","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2fdc03b0-1efe-4389-90d8-0c31f86bb5b6","type":"FunctionalAlteration","dc:description":"This individual (MY1) is compound heterozygous for a null mutation, 1833delT and regulatory mutation ss802470619 (CA268757149), the reduced level of BUB1B expression from the patient lymphoblastoid cells is greater than the cells from individual who is  homozygous for this regulatory mutation. This regulatory mutation is down regulate expression of BUB1B gene.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24344301","rdfs:label":"Western blot"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/052f6a21-9c78-4926-90df-a49bdd163691","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91520238-6d89-4f35-876f-d04784c74562","type":"FunctionalAlteration","dc:description":"FIbroblasts from patient with a germline homozygous intronic mutation, c.2386-11A→G, in  BUB1B, which creates a de novo preferable splice site.\nThe interaction between APC and BUBR1 in the proband’s cells was minimal, despite normal levels of APC. The modified fibroblasts (with a retrovirus containing wild type BUB1B cDNA) and control fibroblasts had similar BUBR levels, which restored the normal interaction. Fibroblasts with modified levels had significantly reduced level of premature chromatid separation (PCS).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21190457","rdfs:label":"Altered APC-BUBR1 interaction"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/59147f27-d5a3-4760-ba8d-0429bae3c906_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48249e51-6a01-4532-8685-1f7a657ac29b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47f78614-5c04-4fb4-880e-7c3cf23498ca","type":"Finding","dc:description":"Introduction of the nt substitution (ss802470619) into normal cultured human cells result in a decrease of BUB1B transcripts and BURB1 protein expression. High rate of premature chromatid separation (PCS) was observed in the clones with biallelic excision.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24344301","rdfs:label":"Functional cytological analysis","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":2029,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/rYj5lnqpmXM","type":"GeneValidityProposition","disease":"obo:MONDO_0009759","gene":"hgnc:1149","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_59147f27-d5a3-4760-ba8d-0429bae3c906-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}